MEDICAL INDUSTRIES OF AMERICA INC
8-K, 1999-04-23
MEDICAL LABORATORIES
Previous: AMPEX CORP /DE/, DEF 14A, 1999-04-23
Next: MEDICAL INDUSTRIES OF AMERICA INC, S-3/A, 1999-04-23



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                   -------------------------------------------

                                       8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

                 ----------------------------------------------


        Date of Report (Date of earliest event reported): April 9, 1999


                       MEDICAL INDUSTRIES OF AMERICA, INC.
             (Exact name of registrant as specified in its Charter)



         FLORIDA                        0-20356                  65-0158479
(State of other jurisdiction      (Commission file no.)       (IRS Employer ID
     of incorporation)                                             Number)


        1903 S. CONGRESS AVENUE, SUITE 400, BOYNTON BEACH, FLORIDA 33426
                    (Address of principal executive offices)


Registrant's telephone number, including area code:  561-737-2227

<PAGE>
Item 2. Acquisition and Disposition of Assets

   (a)       Description of Acquisitions

      On April 9, 1999, the Company, through MIOA Acquisition Company I, Inc.
      and MIOA Acquisition Company VII, Inc. (wholly owned subsidiaries of
      Medical Industries of America, Inc.), executed an agreement and plan of
      merger effective March 1, 1999 with Air Response, Inc. The Company
      received 100% of the outstanding stock of Air Response, Inc. for
      $2,900,000, represented by 3,866,667 shares of the Company's restricted
      common stock with a value of $2,900,000. In addition, the Company will
      issue up to $2,900,000 convertible debentures over three years based on
      earnings, as defined.

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits

            (a)  Financial statements of the businesses acquired, prepared
                 pursuant to Rule 3.05 of Regulation S-X will be filed within 60
                 days in accordance with Item 7(a)4.

            (b)  Pro Forma financial information required pursuant to Article II
                 of Regulation S-X will be filed within 60 days in accordance
                 with Item 7(a)4.

            (c)  Exhibits

                  Exhibit Number         Description
                  --------------         -----------
                       *2           Agreement and Plan of Merger by and among
                                    Medical Industries of America, Inc., MIOA
                                    Acquisition Company I, Inc., MIOA
                                    Acquisition Company VII, Inc., Air Response,
                                    Inc. and Louis R. Capece, Jr. and Donald
                                    Jones.

                 ----------------
                    * To be filed by amendment.



Date: April 22, 1999                By: /s/ ARTHUR KOBRIN
                                            Arthur Kobrin
                                            Chief Financial Officer



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission